Liu L - Search Results

1

Hypoxia associated multi-omics molecular landscape of tumor tissue in patients with hepatocellular carcinoma.

Zhang Q, Qiao L, Liu Q, Kong X, Hu J, Hu W, Wu Z, Li M, Liu L. Zhang Q, et al. Among authors: liu l, liu q. Aging (Albany NY). 2021 Mar 10;13(5):6525-6553. doi: 10.18632/aging.202723. Epub 2021 Mar 10. Aging (Albany NY). 2021. PMID: 33690171 Free PMC article.

2

The E2F1/USP11 positive feedback loop promotes hepatocellular carcinoma metastasis and inhibits autophagy by activating ERK/mTOR pathway.

Qiao L, Zhang Q, Sun Z, Liu Q, Wu Z, Hu W, Bao S, Yang Q, Liu L. Qiao L, et al. Among authors: liu l, liu q. Cancer Lett. 2021 Aug 28;514:63-78. doi: 10.1016/j.canlet.2021.05.015. Epub 2021 May 24. Cancer Lett. 2021. PMID: 34044068

3

A novel machine learning derived RNA-binding protein gene-based score system predicts prognosis of hepatocellular carcinoma patients.

Zhang Q, Zhang Y, Guo Y, Tang H, Li M, Liu L. Zhang Q, et al. Among authors: liu l. PeerJ. 2021 Dec 20;9:e12572. doi: 10.7717/peerj.12572. eCollection 2021. PeerJ. 2021. PMID: 35036125 Free PMC article.

4

Targeting ZBP-89 for the treatment of hepatocellular carcinoma.

Wang N, Wang S, Yang SL, Liu LP, Li MY, Lai PBS, Chen GG. Wang N, et al. Expert Opin Ther Targets. 2018 Oct;22(10):817-822. doi: 10.1080/14728222.2018.1516753. Epub 2018 Sep 6. Expert Opin Ther Targets. 2018. PMID: 30142986 Review.

5

CRISPR/Cas9‑mediated hypoxia inducible factor‑1α knockout enhances the antitumor effect of transarterial embolization in hepatocellular carcinoma.

Liu Q, Fan D, Adah D, Wu Z, Liu R, Yan QT, Zhang Y, Du ZY, Wang D, Li Y, Bao SY, Liu LP. Liu Q, et al. Oncol Rep. 2018 Nov;40(5):2547-2557. doi: 10.3892/or.2018.6667. Epub 2018 Aug 23. Oncol Rep. 2018. PMID: 30226584 Free PMC article.

6

UBE2T promotes hepatocellular carcinoma cell growth via ubiquitination of p53.

Liu LP, Yang M, Peng QZ, Li MY, Zhang YS, Guo YH, Chen Y, Bao SY. Liu LP, et al. Biochem Biophys Res Commun. 2017 Nov 4;493(1):20-27. doi: 10.1016/j.bbrc.2017.09.091. Epub 2017 Sep 18. Biochem Biophys Res Commun. 2017. PMID: 28935368

7

UBE2S enhances the ubiquitination of p53 and exerts oncogenic activities in hepatocellular carcinoma.

Pan YH, Yang M, Liu LP, Wu DC, Li MY, Su SG. Pan YH, et al. Biochem Biophys Res Commun. 2018 Sep 5;503(2):895-902. doi: 10.1016/j.bbrc.2018.06.093. Epub 2018 Jun 20. Biochem Biophys Res Commun. 2018. PMID: 29928880

8

miR-107-mediated decrease of HMGCS2 indicates poor outcomes and promotes cell migration in hepatocellular carcinoma.

Su SG, Yang M, Zhang MF, Peng QZ, Li MY, Liu LP, Bao SY. Su SG, et al. Int J Biochem Cell Biol. 2017 Oct;91(Pt A):53-59. doi: 10.1016/j.biocel.2017.08.016. Epub 2017 Sep 1. Int J Biochem Cell Biol. 2017. PMID: 28867541

9

In Vivo Enrichment and Elimination of Circulating Tumor Cells by Using a Black Phosphorus and Antibody Functionalized Intravenous Catheter.

Wang D, Ge C, Liang W, Yang Q, Liu Q, Ma W, Shi L, Wu H, Zhang Y, Wu Z, Wei C, Huang L, Fang Z, Liu L, Bao S, Zhang H. Wang D, et al. Among authors: liu l, liu q. Adv Sci (Weinh). 2020 Jun 11;7(17):2000940. doi: 10.1002/advs.202000940. eCollection 2020 Sep. Adv Sci (Weinh). 2020. PMID: 32995123 Free PMC article.

10

Cancer stem cells in hepatocellular carcinoma: an overview and promising therapeutic strategies.

Wang N, Wang S, Li MY, Hu BG, Liu LP, Yang SL, Yang S, Gong Z, Lai PBS, Chen GG. Wang N, et al. Ther Adv Med Oncol. 2018 Dec 21;10:1758835918816287. doi: 10.1177/1758835918816287. eCollection 2018. Ther Adv Med Oncol. 2018. PMID: 30622654 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74,162 results

Search Page

Filters